These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. Cai P; Lu P; Sharom FJ; Fang WS Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826 [TBL] [Abstract][Full Text] [Related]
3. Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions. Tang Y; Rodríguez-Salarichs J; Zhao Y; Cai P; Estévez-Gallego J; Balaguer-Pérez F; Redondo Horcajo M; Lucena-Agell D; Barasoain I; Díaz JF; Fang WS Eur J Med Chem; 2017 Sep; 137():488-503. PubMed ID: 28624703 [TBL] [Abstract][Full Text] [Related]
4. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578 [TBL] [Abstract][Full Text] [Related]
5. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules. Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683 [TBL] [Abstract][Full Text] [Related]
6. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site. Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889 [TBL] [Abstract][Full Text] [Related]
7. Relationship between the structures of taxane derivatives and their microtubule polymerization activity. Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785 [TBL] [Abstract][Full Text] [Related]
8. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel. Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of action of microtubule-stabilizing anticancer agents. Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720 [TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models. Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771 [TBL] [Abstract][Full Text] [Related]
11. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones. Manetti F; Maccari L; Corelli F; Botta M Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454 [TBL] [Abstract][Full Text] [Related]
12. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341 [TBL] [Abstract][Full Text] [Related]
13. The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance. Ferlini C; Raspaglio G; Mozzetti S; Cicchillitti L; Filippetti F; Gallo D; Fattorusso C; Campiani G; Scambia G Cancer Res; 2005 Mar; 65(6):2397-405. PubMed ID: 15781655 [TBL] [Abstract][Full Text] [Related]
14. Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies. Zhu L; Zhang C; Lü X; Song C; Wang C; Zhang M; Xie Y; Schaefer HF J Mol Model; 2020 May; 26(6):162. PubMed ID: 32474655 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies on biological activity of certain microtubule-interacting taxanes. Miglietta A; Bocca C; Gabriel L Chem Biol Interact; 2002 Mar; 139(3):283-99. PubMed ID: 11879817 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics and tubulin polymerization kinetics study on 1,14-heterofused taxanes: evidence of stabilization of the tubulin head-to-tail dimer-dimer interaction. Contini A; Cappelletti G; Cartelli D; Fontana G; Gelmi ML Mol Biosyst; 2012 Oct; 8(12):3254-61. PubMed ID: 23073462 [TBL] [Abstract][Full Text] [Related]